BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT. Temporal Trends of Invasive Disease Due to Streptococcus pneumoniae among Children in the Intermountain West: Emergence of Nonvaccine Serogroups. Clinical Infectious Diseases 2005;41:21-9. [DOI: 10.1086/430604] [Cited by in Crossref: 179] [Cited by in F6Publishing: 170] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Gupta R, Crowley S. Increasing paediatric empyema admissions. Thorax 2006;61:179-80. [PMID: 16443710 DOI: 10.1136/thx.2005.049510] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
2 Whitney CG, Moore MR. Direct and Indirect Effectiveness and Safety of Pneumococcal Conjugate Vaccine in Practice. In: Siber GR, Klugman KP, Helena Mäkelä P, editors. Pneumococcal Vaccines. Washington: ASM Press; 2008. pp. 351-68. [DOI: 10.1128/9781555815820.ch24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Burgos J, Lujan M, Falco V, Sanchez A, Puig M, Borrego A, Fontanals D, Planes AM, Pahissa A, Rello J. The Spectrum of Pneumococcal Empyema in Adults in the Early 21st Century. Clinical Infectious Diseases 2011;53:254-61. [DOI: 10.1093/cid/cir354] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
4 Leibovitz E. The effect of vaccination on Streptococcus pneumoniae resistance. Curr Infect Dis Rep 2008;10:182-91. [DOI: 10.1007/s11908-008-0031-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
5 Zhan X, Martin LN, Slobod KS, Coleclough C, Lockey TD, Brown SA, Stambas J, Bonsignori M, Sealy RE, Blanchard JL, Hurwitz JL. Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV. Vaccine 2005;23:5306-20. [PMID: 16095768 DOI: 10.1016/j.vaccine.2005.07.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
6 Simon AE, Lukacs SL, Mendola P. National trends in emergency department use of urinalysis, complete blood count, and blood culture for fever without a source among children aged 2 to 24 months in the pneumococcal conjugate vaccine 7 era. Pediatr Emerg Care 2013;29:560-7. [PMID: 23603643 DOI: 10.1097/PEC.0b013e31828e56e1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis 2008;47:1367-71. [PMID: 18945210 DOI: 10.1086/592970] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mahajan P, Stanley R. Fever in the Toddler-Aged Child: Old Concerns Replaced With New Ones. Clinical Pediatric Emergency Medicine 2008;9:221-7. [DOI: 10.1016/j.cpem.2008.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J 2011;30:1100-3. [PMID: 22005513 DOI: 10.1097/INF.0b013e318232ee3e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Lai CY, Huang LM, Lee PY, Lu CY, Shao PL, Chang LY. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease. J Microbiol Immunol Infect 2014;47:23-7. [PMID: 23040234 DOI: 10.1016/j.jmii.2012.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
11 Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG. Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule. Sci Rep 2018;8:17959. [PMID: 30568178 DOI: 10.1038/s41598-018-35921-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
12 Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76. [PMID: 21880587 DOI: 10.1093/cid/cir531] [Cited by in Crossref: 686] [Cited by in F6Publishing: 595] [Article Influence: 62.4] [Reference Citation Analysis]
13 Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2013. pp. 504-41. [DOI: 10.1016/b978-1-4557-0090-5.00032-x] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Chibuk TK, Robinson JL, Hartfield DS. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr. 2010;169:1123-1128. [PMID: 20383524 DOI: 10.1007/s00431-010-1195-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
15 Salleras L, Domínguez A, Ciruela P, Izquierdo C, Navas E, Torner N, Borras E. Changes in serotypes causing invasive pneumococcal disease (2005–2007 vs. 1997–1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. Clinical Microbiology and Infection 2009;15:997-1001. [DOI: 10.1111/j.1469-0691.2009.02938.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
16 Martinón-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez Campderá JA, Picazo JJ, Pineda Solas V. [Why are pediatric empyemas on the increase in Spain?]. An Pediatr (Barc) 2008;68:158-64. [PMID: 18341884 DOI: 10.1157/13116233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Wroe PC, Lee GM, Finkelstein JA, Pelton SI, Hanage WP, Lipsitch M, Stevenson AE, Rifas-Shiman SL, Kleinman K, Dutta-Linn MM. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012;31:249-254. [PMID: 22173142 DOI: 10.1097/inf.0b013e31824214ac] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
18 Scott J. The preventable burden of pneumococcal disease in the developing world. Vaccine 2007;25:2398-405. [DOI: 10.1016/j.vaccine.2006.09.008] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
19 Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM. Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Expert Rev Vaccines 2009;8:1705-20. [PMID: 19905872 DOI: 10.1586/erv.09.133] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
20 Granat SM, Mia Z, Ollgren J, Herva E, Das M, Piirainen L, Auranen K, Mäkelä PH. Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh. Pediatr Infect Dis J 2007;26:319-24. [PMID: 17414395 DOI: 10.1097/01.inf.0000257425.24492.11] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
21 Abuelreish M, Subedar A, Chiu T, Wludyka P, Rathore M. Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine. Clin Pediatr (Phila) 2007;46:45-52. [PMID: 17164509 DOI: 10.1177/0009922806289322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Balaji V, Jayaraman R, Verghese VP, Baliga PR, Kurien T. Pneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy. Indian J Med Res 2015;142:286-92. [PMID: 26458344 DOI: 10.4103/0971-5916.166588] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
23 Fletcher MA, Schmitt HJ, Syrochkina M, Sylvester G. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis 2014;33:879-910. [PMID: 24563274 DOI: 10.1007/s10096-014-2062-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
24 Fritzell B, Fletcher MA. Pneumococcal polysaccharide–protein (CRM 197 ) conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule. Expert Review of Vaccines 2014;10:263-90. [DOI: 10.1586/erv.11.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012. J Infect Dis 2014;209:1251-8. [PMID: 24273178 DOI: 10.1093/infdis/jit642] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
26 Black S, Eskola J, Whitney C, Shinefield H. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2008. pp. 531-67. [DOI: 10.1016/b978-1-4160-3611-1.50027-1] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Rodríguez-Créixems M, Alcalá L, Muñoz P, Cercenado E, Vicente T, Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 2008;87:234-49. [PMID: 18626306 DOI: 10.1097/MD.0b013e318182119b] [Cited by in Crossref: 62] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
28 Iliopoulou M, Skouras V, Psaroudaki Z, Makarona M, Vogiatzakis E, Tsorlini E, Katsifa E, Spyratos D, Siopi D, Kotsiou O, Xitsas S, Martsoukou M, Sigala I, Kalomenidis I. Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection. J Thorac Dis 2021;13:521-32. [PMID: 33717525 DOI: 10.21037/jtd-20-2786] [Reference Citation Analysis]
29 . Emergence of Antimicrobial-Resistant Serotype 19A Streptococcus pneumoniae—Massachusetts, 2001-2006. Annals of Emergency Medicine 2008;51:312-4. [DOI: 10.1016/j.annemergmed.2008.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL. Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hospital Pediatrics 2015;5:605-12. [DOI: 10.1542/hpeds.2015-0100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
31 Esposito S, Tansey S, Thompson A, Razmpour A, Liang J, Jones TR, Ferrera G, Maida A, Bona G, Sabatini C, Pugni L, Emini EA, Gruber WC, Scott DA, Principi N. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers. Clin Vaccine Immunol 2010;17:1017-26. [PMID: 20427630 DOI: 10.1128/CVI.00062-10] [Cited by in Crossref: 114] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
32 Long SS. Capsules, Clones, and Curious Events: Pneumococcus under Fire from Polysaccharide Conjugate Vaccine. Clinical Infectious Diseases 2005;41:30-4. [DOI: 10.1086/430608] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
33 Hammitt LL, Akech DO, Morpeth SC, Karani A, Kihuha N, Nyongesa S, Bwanaali T, Mumbo E, Kamau T, Sharif SK, Scott JA. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health 2014;2:e397-405. [PMID: 25103393 DOI: 10.1016/S2214-109X(14)70224-4] [Cited by in Crossref: 147] [Cited by in F6Publishing: 80] [Article Influence: 18.4] [Reference Citation Analysis]
34 Ardanuy C, Marimón JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallarés R, Pérez-Trallero E, Liñares J. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One 2012;7:e43619. [PMID: 22928005 DOI: 10.1371/journal.pone.0043619] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
35 Tasslimi A, Wenger P, Pentakota SR, Brimacombe M, Burday M, Sinha A. Invasive pneumococcal disease in an underimmunized, high HIV prevalence population. Journal of Infection 2008;56:99-102. [DOI: 10.1016/j.jinf.2007.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
36 Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008;46:174-82. [PMID: 18171247 DOI: 10.1086/524660] [Cited by in Crossref: 259] [Cited by in F6Publishing: 229] [Article Influence: 18.5] [Reference Citation Analysis]
37 François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr 2010;99:861-6. [PMID: 20178517 DOI: 10.1111/j.1651-2227.2010.01734.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
38 Karnezis TT, Smith A, Whittier S, Haddad J, Saiman L. Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine. PLoS One 2009;4:e5965. [PMID: 19536335 DOI: 10.1371/journal.pone.0005965] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
39 Käyhty H, Auranen K, Nohynek H, Dagan R, Mäkelä H. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines 2006;5:651-67. [PMID: 17181439 DOI: 10.1586/14760584.5.5.651] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
40 Pettigrew MM, Fennie KP, York MP, Daniels J, Ghaffar F. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun 2006;74:3360-5. [PMID: 16714565 DOI: 10.1128/IAI.01442-05] [Cited by in Crossref: 91] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
41 Rodríguez MA, González AV, Gavín MA, Martínez FM, Marín NG, Blázquez BR, Moreno JC. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine 2011;29:5740-6. [PMID: 21683112 DOI: 10.1016/j.vaccine.2011.05.099] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
42 Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011;378:1962-73. [PMID: 21492929 DOI: 10.1016/S0140-6736(10)62225-8] [Cited by in Crossref: 631] [Cited by in F6Publishing: 329] [Article Influence: 57.4] [Reference Citation Analysis]
43 Scheifele DW, Halperin SA, Ochnio JJ, Mozel M, Duarte-monteiro D, Wortzman D. Immunologic Considerations for the Timing of the Booster Dose of 7-Valent Pneumococcal Conjugate Vaccine in Young Children. Pediatric Infectious Disease Journal 2007;26:387-92. [DOI: 10.1097/01.inf.0000259955.66171.0c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Burgos J, Falcó V, Borrego A, Sordé R, Larrosa MN, Martinez X, Planes AM, Sánchez A, Palomar M, Rello J, Pahissa A. Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect 2013;19:385-91. [PMID: 22583156 DOI: 10.1111/j.1469-0691.2012.03895.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
45 Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Pediatr Infect Dis J 2008;27:886-91. [PMID: 18776825 DOI: 10.1097/INF.0b013e3181734f8f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
46 Motlova J, Benes C, Kriz P. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006. Epidemiol Infect 2009;137:562-9. [PMID: 18796171 DOI: 10.1017/S0950268808001301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
47 Muñoz-almagro C, Selva L, Pallares R. Influence of pneumococcal vaccine on the incidence of empyema: . Current Opinion in Pulmonary Medicine 2010;16:394-8. [DOI: 10.1097/mcp.0b013e328338c19f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
48 Zampoli M, Chaya S, Zar HJ. Empyema in Children: Update of Aetiology, Diagnosis and Management Approaches. Curr Pulmonol Rep 2017;6:16-25. [DOI: 10.1007/s13665-017-0161-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
49 Souli M, Volonakis K, Kapaskelis A, Galani I, Grammelis V, Vorou R, Tsivra M, Chryssouli Z, Katsala D, Giamarellou H. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003. Clinical Microbiology and Infection 2007;13:70-7. [DOI: 10.1111/j.1469-0691.2006.01555.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
50 Metlay JP, Lautenbach E, Li Y, Shults J, Edelstein PH. Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med 2010;170:725-31. [PMID: 20421560 DOI: 10.1001/archinternmed.2010.53] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
51 Hill PC, Akisanya A, Sankareh K, Cheung YB, Saaka M, Lahai G, Greenwood BM, Adegbola RA. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 2006;43:673-9. [PMID: 16912937 DOI: 10.1086/506941] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 7.3] [Reference Citation Analysis]
52 Hagerman A, Posfay-Barbe KM, Grillet S, Ochs MM, Brookes RH, Greenberg D, Givon-Lavi N, Dagan R, Siegrist CA. Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children. Eur J Clin Microbiol Infect Dis 2013;32:43-9. [PMID: 22903166 DOI: 10.1007/s10096-012-1712-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
53 Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J. 2010;29:294-300. [PMID: 19949357 DOI: 10.1097/inf.0b013e3181c2a229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
54 Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S, Wanjiru E, Jomo J, Musyimi R, Lipsitch M, Scott JA. The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One 2012;7:e30787. [PMID: 22363489 DOI: 10.1371/journal.pone.0030787] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
55 Shouval DS, Greenberg D, Givon-lavi N, Porat N, Dagan R. Site-Specific Disease Potential of Individual Streptococcus pneumoniae Serotypes in Pediatric Invasive Disease, Acute Otitis Media and Acute Conjunctivitis. Pediatric Infectious Disease Journal 2006;25:602-7. [DOI: 10.1097/01.inf.0000220231.79968.f6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 7.3] [Reference Citation Analysis]
56 Stockmann C, Ampofo K, Pavia AT, Blaschke AJ, Mason EO, Presson AP, Forney LJ, Byington CL. Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis 2016;63:619-26. [PMID: 27282711 DOI: 10.1093/cid/ciw357] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
57 Goettler D, Streng A, Kemmling D, Schoen C, von Kries R, Rose MA, van der Linden M, Liese JG. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Vaccine 2020;38:570-7. [PMID: 31735502 DOI: 10.1016/j.vaccine.2019.10.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
58 Peltola V, Ruuskanen O, Svedström E. Magnetic resonance imaging of lung infections in children. Pediatr Radiol 2008;38:1225-31. [DOI: 10.1007/s00247-008-0987-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
59 Bueno Campaña M, Agúndez Reigosa B, Jimeno Ruiz S, Echávarri Olavarría F, Martínez Granero MA. [Is the incidence of parapneumonic pleural effusion increasing?]. An Pediatr (Barc) 2008;68:92-8. [PMID: 18341872 DOI: 10.1157/13116221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
60 Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. The Lancet Infectious Diseases 2006;6:405-10. [DOI: 10.1016/s1473-3099(06)70520-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
61 Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO. Streptococcus pneumoniae Serogroups 15 and 33: An Increasing Cause of Pneumococcal Infections in Children in the United States After the Introduction of the Pneumococcal 7-Valent Conjugate Vaccine. The Pediatric Infectious Disease Journal 2006;25:301-5. [DOI: 10.1097/01.inf.0000207484.52850.38] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
62 Tsang R. Capsule switching and capsule replacement in vaccine-preventable bacterial diseases. The Lancet Infectious Diseases 2007;7:569-70. [DOI: 10.1016/s1473-3099(07)70191-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
63 Zhuo F, Xiao M, Kong F, Oftadeh S, Zhou F, Zhang J, Gilbert GL. Prevalence and genetic diversity of pneumococcal serogroup 6 in Australia. Clin Microbiol Infect 2011;17:1246-53. [PMID: 20950338 DOI: 10.1111/j.1469-0691.2010.03404.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
64 Whitney CG. Can Vaccines Control Resistance? The Example of Pneumococcal Conjugate Vaccine. Infectious Diseases in Clinical Practice 2006;14:S24-30. [DOI: 10.1097/01.idc.0000230541.02089.8c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
65 Lin W, Lo W, Chou C, Chen Y, Tsai S, Chu M, Wang C. Antimicrobial resistance patterns and serotype distribution of invasive Streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004. Diagnostic Microbiology and Infectious Disease 2006;56:189-96. [DOI: 10.1016/j.diagmicrobio.2006.03.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
66 Shen CF, Wang SM, Lee KH, Ho TS, Liu CC. Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan. J Formos Med Assoc 2013;112:561-8. [PMID: 23916313 DOI: 10.1016/j.jfma.2013.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
67 Trotter CL, Mcvernon J, Ramsay ME, Whitney CG, Mulholland EK, Goldblatt D, Hombach J, Kieny M. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008;26:4434-45. [DOI: 10.1016/j.vaccine.2008.05.073] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 7.6] [Reference Citation Analysis]
68 Elliott SP. Antimicrobial-resistant pathogens: an emerging pediatric threat. Adv Pediatr 2008;55:329-48. [PMID: 19048737 DOI: 10.1016/j.yapd.2008.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
69 Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007;3:e168. [PMID: 18020702 DOI: 10.1371/journal.ppat.0030168] [Cited by in Crossref: 271] [Cited by in F6Publishing: 254] [Article Influence: 19.4] [Reference Citation Analysis]
70 Clarke SC. Control of pneumococcal disease in the United Kingdom – the start of a new era. Journal of Medical Microbiology 2006;55:975-80. [DOI: 10.1099/jmm.0.46579-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
71 Gruber WC, Scott DA, Emini EA. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine. Ann N Y Acad Sci. 2012;1263:15-26. [PMID: 22830997 DOI: 10.1111/j.1749-6632.2012.06673.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
72 Ceyhan M, Yildirim I, Sheppard CL, George RC. Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur J Clin Microbiol Infect Dis 2010;29:289-93. [PMID: 20087750 DOI: 10.1007/s10096-009-0853-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
73 Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, Greenwood BM, Adegbola RA. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 2008;46:807-14. [PMID: 18279039 DOI: 10.1086/528688] [Cited by in Crossref: 120] [Cited by in F6Publishing: 116] [Article Influence: 8.6] [Reference Citation Analysis]
74 Regev-Yochay G, Rahav G, Riesenberg K, Wiener-Well Y, Strahilevitz J, Stein M, Glikman D, Weber G, Potasman I, Dagan R; IAIPD study group. Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel. PLoS One 2014;9:e88406. [PMID: 24516649 DOI: 10.1371/journal.pone.0088406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
75 Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL. Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis 2009;15:44-8. [PMID: 19116048 DOI: 10.3201/eid1501.080618] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
76 Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; on behalf of the Oxford Invasive Pneumococcal Surveillance Group. Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England. Journal of Medical Microbiology 2008;57:480-7. [DOI: 10.1099/jmm.0.47690-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
77 Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013;10:e1001517. [PMID: 24086113 DOI: 10.1371/journal.pmed.1001517] [Cited by in Crossref: 324] [Cited by in F6Publishing: 293] [Article Influence: 36.0] [Reference Citation Analysis]
78 Azzari C, Moriondo M, Cortimiglia M, Valleriani C, Canessa C, Indolfi G, Ricci S, Nieddu F, de Martino M, Resti M; Italian group for the study of Invasive Pneumococcal Disease. Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children. Vaccine 2012;30:2701-5. [PMID: 22178097 DOI: 10.1016/j.vaccine.2011.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
79 Muñoz-almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. Journal of Infection 2011;63:151-62. [DOI: 10.1016/j.jinf.2011.06.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
80 Park C, Kwon EY, Choi SM, Cho SY, Byun JH, Park JY, Lee DG, Kang JH, Shin J, Kim H. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model. Hum Vaccin Immunother 2017;13:1169-76. [PMID: 27960627 DOI: 10.1080/21645515.2016.1261772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
81 Desrumaux A, François P, Pascal C, Cans C, Croizé J, Gout JP, Pin I. [Epidemiology and clinical characteristics of childhood parapneumonic empyemas]. Arch Pediatr 2007;14:1298-303. [PMID: 17631988 DOI: 10.1016/j.arcped.2007.06.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
82 Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009;124:e1-11. [PMID: 19564254 DOI: 10.1542/peds.2008-3099] [Cited by in Crossref: 215] [Cited by in F6Publishing: 202] [Article Influence: 16.5] [Reference Citation Analysis]
83 Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, Nahm MH. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 2012;287:27885-94. [PMID: 22736767 DOI: 10.1074/jbc.M112.380451] [Cited by in Crossref: 109] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
84 Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis 2008;46:1346-52. [PMID: 18419434 DOI: 10.1086/586747] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 6.7] [Reference Citation Analysis]
85 Ruiz-contreras J. Vacunas neumocócicas conjugadas: presente y futuro. Enfermedades Infecciosas y Microbiología Clínica 2008;26:48-55. [DOI: 10.1016/s0213-005x(08)76224-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Falcó V, Sánchez A, Pahissa A, Rello J. Emerging drugs for pneumococcal pneumonia. Expert Opinion on Emerging Drugs 2011;16:459-77. [DOI: 10.1517/14728214.2011.576669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez M, Rolo D, Grau I, Martín R, Liñares J. Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007. CLIN INFECT DIS 2009;48:57-64. [DOI: 10.1086/594125] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 11.0] [Reference Citation Analysis]
88 Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011;30:289-94. [PMID: 21057372 DOI: 10.1097/INF.0b013e3182002d14] [Cited by in Crossref: 86] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
89 Steenhoff AP, Shah SS, Ratner AJ, Patil SM, Mcgowan KL. Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia. Clinical Infectious Diseases 2006;42:907-14. [DOI: 10.1086/500941] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
90 Walker SG, Carnu OI, Tüter G, Ryan ME. The immunoglobulin A1 proteinase from Streptococcus pneumoniae is inhibited by tetracycline compounds. FEMS Immunol Med Microbiol 2006;48:218-22. [DOI: 10.1111/j.1574-695x.2006.00148.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Singh A, Dutta AK. Pneumococcal Vaccines - How Many Serotypes are Enough? Indian J Pediatr 2018;85:47-52. [PMID: 28887787 DOI: 10.1007/s12098-017-2449-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 Maataoui N, Bidet P, Doit C, De Lauzanne A, Lorrot M, Mariani-Kurkdjian P, Faye A, Bingen E. A multiplex polymerase chain reaction method for rapid pneumococcal serotype determination in childhood empyema. Diagn Microbiol Infect Dis 2011;69:245-9. [PMID: 21353946 DOI: 10.1016/j.diagmicrobio.2010.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
93 Castañeda E, Agudelo CI, Regueira M, Corso A, de Cunto Brandileone MC, Brandão AP, Maldonado A, Hormazabal JC, Martínez IT, Llanes R, Sánchez J, Feris JM, Echaniz-aviles G, Carnalla-barajas MN, Terrazas MGV, Monroy IH, Chamorro G, Weiler N, Camou T, Gabarrot GG, Spadola E, Payares D, Gabastou JM, Di Fabio JL, de la Hoz F. Laboratory-Based Surveillance of Streptococcus pneumoniae Invasive Disease in Children in 10 Latin American Countries: A SIREVA II Project, 2000–2005. Pediatric Infectious Disease Journal 2009;28:e265-70. [DOI: 10.1097/inf.0b013e3181a74b22] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
94 Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, Kleinman K, Hinrichsen VL, Fraser C. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010;2:80-4. [PMID: 21031138 DOI: 10.1016/j.epidem.2010.03.005] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 10.1] [Reference Citation Analysis]
95 Thomas JC, Figueira M, Fennie KP, Laufer AS, Kong Y, Pichichero ME, Pelton SI, Pettigrew MM. Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence. PLoS One 2011;6:e18649. [PMID: 21533186 DOI: 10.1371/journal.pone.0018649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
96 Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis 2012;18:208-16. [PMID: 22306234 DOI: 10.3201/eid1802.110714] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
97 Khoshdel A, Rastabi RI, Doosti A, Askari S, Hafizi M. Prevalence of Heptavalent Vaccine-related Pneumococcal Serotypes in Nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during 2010- 2011. J Clin Diagn Res 2014;8:PC01-4. [PMID: 25584276 DOI: 10.7860/JCDR/2014/8970.5104] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
98 Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-1027. [PMID: 18419539 DOI: 10.1086/528996] [Cited by in Crossref: 382] [Cited by in F6Publishing: 365] [Article Influence: 27.3] [Reference Citation Analysis]
99 Nakano T, Watanabe M, Saitoh A, Suga S, Oishi K, Nishimura N. Symposium report of the 17th annual meeting of the Japanese Society for Vaccinology, 2013: Bacterial vaccines: Effectiveness and issues. Vaccine 2016;34:1956-7. [PMID: 26431988 DOI: 10.1016/j.vaccine.2015.09.084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Arguedas A, Soley C, Abdelnour A. Prevenar experience. Vaccine 2011;29:C26-34. [DOI: 10.1016/j.vaccine.2011.06.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
101 Ricketson LJ, Conradi NG, Vanderkooi OG, Kellner JD. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada. Pediatric Infectious Disease Journal 2018;37:22-7. [DOI: 10.1097/inf.0000000000001709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
102 Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics 2013;132:e17-24. [PMID: 23733800 DOI: 10.1542/peds.2012-3900] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
103 Barricarte A, Castilla J, Setas AG, Torroba L, Alonso JAN, Irisarri F, Arriazu M. Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Case-Control Study. Clinical Infectious Diseases 2007;44:1436-41. [DOI: 10.1086/516779] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
104 Andrade AL, Toscano CM, Minamisava R, Costa PS, Andrade JG. Pneumococcal disease manifestation in children before and after vaccination: what's new? Vaccine 2011;29 Suppl 3:C2-14. [PMID: 21896349 DOI: 10.1016/j.vaccine.2011.06.096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
105 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
106 Fletcher M, Leeming J, Cartwright K, Finn A. CHILDHOOD EMPYEMA: LIMITED POTENTIAL IMPACT OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE. Pediatric Infectious Disease Journal 2006;25:559-60. [DOI: 10.1097/01.inf.0000219535.14201.1b] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
107 Steenhoff AP, Josephs JS, Rutstein RM, Gebo KA, Siberry GK, Gaur AH, Warford R, Korthuis PT, Spector SA, Shah SS. Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000-2005. AIDS 2011;25:717-20. [PMID: 21252630 DOI: 10.1097/QAD.0b013e3283440583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
108 Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Review of Vaccines 2014;7:1367-94. [DOI: 10.1586/14760584.7.9.1367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
109 Spencer DC. Preventing bacterial disease in the HIV-infected of sub-saharan africa: The role of cotrimoxazole and the pneumococcal vaccines. Curr HIV/AIDS Rep 2007;4:141-6. [DOI: 10.1007/s11904-007-0021-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
110 Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the Pneumococcal Conjugate Vaccine on Pneumococcal Parapneumonic Empyema: . The Pediatric Infectious Disease Journal 2006;25:250-4. [DOI: 10.1097/01.inf.0000202137.37642.ab] [Cited by in Crossref: 185] [Cited by in F6Publishing: 152] [Article Influence: 11.6] [Reference Citation Analysis]
111 Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis. 2011;53:137-143. [PMID: 21690620 DOI: 10.1093/cid/cir326] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
112 Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, Saitoh A, Oishi T, Hosoya M, Togashi T, Oishi K, Ihara T. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine. Vaccine 2015;33:6054-60. [PMID: 26235372 DOI: 10.1016/j.vaccine.2015.07.069] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
113 Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008;27:59-64. [PMID: 18162940 DOI: 10.1097/INF.0b013e31814da70c] [Cited by in Crossref: 118] [Cited by in F6Publishing: 78] [Article Influence: 8.4] [Reference Citation Analysis]
114 Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. The Lancet Infectious Diseases 2008;8:785-95. [DOI: 10.1016/s1473-3099(08)70281-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
115 Pérez-Rodríguez MT, Sopeña B, Méndez-Lage S, Casares Mde L, Constenla L, Argibay A, Nodar A, Villaverde I, Martínez-Vázquez C, Álvarez-fernández M. [Influence of age on the clinical manifestations of invasive pneumococcal disease and antibiotic resistance rates]. Med Clin (Barc) 2014;143:287-92. [PMID: 24120104 DOI: 10.1016/j.medcli.2013.07.023] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011;66:663-8. [PMID: 21617169 DOI: 10.1136/thx.2010.156406] [Cited by in Crossref: 151] [Cited by in F6Publishing: 118] [Article Influence: 13.7] [Reference Citation Analysis]
117 Hsieh YC, Wang JT, Lee WS, Hsueh PR, Shao PL, Chang LY, Lu CY, Lee CY, Huang FY, Huang LM. Serotype competence and penicillin resistance in Streptococcus pneumoniae. Emerg Infect Dis 2006;12:1709-14. [PMID: 17283621 DOI: 10.3201/eid1211.060414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
118 Amrine-Madsen H, Van Eldere J, Mera RM, Miller LA, Poupard JA, Thomas ES, Halsey WS, Becker JA, O'Hara FP. Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004. Antimicrob Agents Chemother 2008;52:3216-20. [PMID: 18573928 DOI: 10.1128/AAC.00358-08] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
119 Toledo ME, Casanova MF, Linares-Pérez N, García-Rivera D, Toraño Peraza G, Barcos Pina I, Montes de Oca M, Rodriguez-Noda LM, Mirabal M, Paredes B, Chávez Amaro DM, Santana Mederos D, Valdés-Balbín Y, Verez-Bencomo V; Finlay Vaccine Institute Laboratory-Pneumococci Group and Cienfuegos Local Research Team Pneumococci Project. Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba. Pediatr Infect Dis J 2017;36:e22-8. [PMID: 27649366 DOI: 10.1097/INF.0000000000001341] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
120 Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One 2017;12:e0177113. [PMID: 28486544 DOI: 10.1371/journal.pone.0177113] [Cited by in Crossref: 164] [Cited by in F6Publishing: 138] [Article Influence: 32.8] [Reference Citation Analysis]
121 Dagan R, Barkai G, Leibovitz E, Dreifuss E, Greenberg D. Will Reduction of Antibiotic Use Reduce Antibiotic Resistance?: The Pneumococcus Paradigm. The Pediatric Infectious Disease Journal 2006;25:981-6. [DOI: 10.1097/01.inf.0000239266.20642.26] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
122 Porat N, Soley C, Marengolciene MM, Greenberg D, Givon-lavi N, Trefler R, Arguedas A, Dagan R. An International Serotype 3 Clone Causing Pediatric Noninvasive Infections in Israel, Costa Rica, and Lithuania. Pediatric Infectious Disease Journal 2008;27:709-12. [DOI: 10.1097/inf.0b013e31816fca86] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
123 Rivera-olivero IA, Blommaart M, Bogaert D, Hermans PWM, de Waard JH. Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-valent conjugate vaccine serotypes co-colonizing indigenous Warao children in Venezuela. Journal of Medical Microbiology 2009;58:584-7. [DOI: 10.1099/jmm.0.006726-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
124 Haddad MB, Porucznik CA, Joyce KE, De AK, Pavia AT, Rolfs RT, Byington CL. Risk Factors for Pediatric Invasive Pneumococcal Disease in the Intermountain West, 1996–2002. Annals of Epidemiology 2008;18:139-46. [DOI: 10.1016/j.annepidem.2007.09.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
125 Posfay-Barbe KM, Siegrist CA. Immunization and transplantation--what is new and what is coming? Pediatr Transplant 2009;13:404-10. [PMID: 19032408 DOI: 10.1111/j.1399-3046.2008.01103.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
126 Moore MR, Whitney CG. Emergence of Nonvaccine Serotypes following Introduction of Pneumococcal Conjugate Vaccine: Cause and Effect? Clinical Infectious Diseases 2008;46:183-5. [DOI: 10.1086/524661] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
127 Langley JM, Kellner JD, Solomon N, Robinson JL, Le Saux N, McDonald J, Ulloa-Gutierrez R, Tan B, Allen U, Dobson S, Joudrey H. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2008;8:129. [PMID: 18816409 DOI: 10.1186/1471-2334-8-129] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
128 Lee GM, Kleinman K, Pelton S, Lipsitch M, Huang SS, Lakoma M, Dutta-Linn M, Rett M, Hanage WP, Finkelstein JA. Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period. Pediatrics 2017;140:e20170001. [PMID: 28978716 DOI: 10.1542/peds.2017-0001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
129 Messina AF, Katz-gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, Mccracken GH. Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Antimicrobial Resistance of Invasive Streptococcus pneumoniae Isolates in Dallas, TX, Children From 1999 Through 2005. Pediatric Infectious Disease Journal 2007;26:461-7. [DOI: 10.1097/inf.0b013e31805cdbeb] [Cited by in Crossref: 122] [Cited by in F6Publishing: 37] [Article Influence: 8.1] [Reference Citation Analysis]
130 Al-Sabbagh A, Catford K, Evans I, Morley SL. Severe cardiovascular and thromboembolic consequences of pneumococcal infection in a child. Pediatrics 2008;122:e945-7. [PMID: 18829789 DOI: 10.1542/peds.2008-0725] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
131 McIntosh ED, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines 2011;10:109-29. [PMID: 21162625 DOI: 10.1586/erv.10.145] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
132 Obando Santaella I, Sánchez Tatay D, Mateos Wichmann I, Torronteras Santiago R, León Leal JA. [Increase in the incidence of parapneumonic pleural effusions]. An Pediatr (Barc) 2006;64:176-7. [PMID: 16527076 DOI: 10.1157/13084183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
133 Mizrachi Nebenzahl Y, Blau K, Kushnir T, Shagan M, Portnoi M, Cohen A, Azriel S, Malka I, Adawi A, Kafka D, Dotan S, Guterman G, Troib S, Fishilevich T, Gershoni JM, Braiman A, Mitchell AM, Mitchell TJ, Porat N, Goliand I, Chalifa Caspi V, Swiatlo E, Tal M, Ellis R, Elia N, Dagan R. Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine. PLoS One 2016;11:e0150320. [PMID: 26990554 DOI: 10.1371/journal.pone.0150320] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
134 McLaughlin JM, Utt EA, Hill NM, Welch VL, Power E, Sylvester GC. A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States. Hum Vaccin Immunother 2016;12:206-12. [PMID: 26376039 DOI: 10.1080/21645515.2015.1069452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
135 Calbo E, Díaz A, Cañadell E, Fábrega J, Uriz S, Xercavins M, Morera MA, Cuchi E, Rodríguez-Carballeira M, Garau J; Spanish Pneumococcal Infection Study Network. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2006;12:867-72. [PMID: 16882291 DOI: 10.1111/j.1469-0691.2006.1502_1.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 6.1] [Reference Citation Analysis]
136 Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010;29:304-9. [PMID: 19935445 DOI: 10.1097/INF.0b013e3181c1bc48] [Cited by in Crossref: 99] [Cited by in F6Publishing: 120] [Article Influence: 8.3] [Reference Citation Analysis]
137 Dias R, Caniça M. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 2007;51:35-42. [PMID: 17854472 DOI: 10.1111/j.1574-695X.2007.00283.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
138 Obaro S. Seven-valent pneumococcal conjugate vaccines for developing countries. Expert Rev Vaccines 2009;8:1051-61. [PMID: 19627187 DOI: 10.1586/erv.09.66] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
139 Laufer AS, Thomas JC, Figueira M, Gent JF, Pelton SI, Pettigrew MM. Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine. Vaccine 2010;28:2450-7. [PMID: 20067753 DOI: 10.1016/j.vaccine.2009.12.078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
140 Azzari C, Moriondo M, Indolfi G, Cortimiglia M, Canessa C, Becciolini L, Lippi F, de Martino M, Resti M. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One 2010;5:e9282. [PMID: 20174571 DOI: 10.1371/journal.pone.0009282] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 7.0] [Reference Citation Analysis]
141 Gadzinowski J, Albrecht P, Hasiec B, Konior R, Dziduch J, Witor A, Mellelieu T, Tansey SP, Jones T, Sarkozy D, Emini EA, Gruber WC, Scott DA. Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine. Vaccine 2011;29:2947-55. [DOI: 10.1016/j.vaccine.2011.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
142 Alekshun M, Levy S. Commensals upon us. Biochemical Pharmacology 2006;71:893-900. [DOI: 10.1016/j.bcp.2005.12.040] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
143 Pandya GA, McEllistrem MC, Venepally P, Holmes MH, Jarrahi B, Sanka R, Liu J, Karamycheva SA, Bai Y, Fleischmann RD, Peterson SN. Monitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains. PLoS One 2011;6:e15950. [PMID: 21264340 DOI: 10.1371/journal.pone.0015950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
144 Guevara M, Barricarte A, Gil-Setas A, García-Irure JJ, Beristain X, Torroba L, Petit A, Polo Vigas ME, Aguinaga A, Castilla J. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009;15:1013-1019. [PMID: 19673968 DOI: 10.1111/j.1469-0691.2009.02904.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
145 Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010;48:520-5. [PMID: 20018815 DOI: 10.1128/JCM.01200-09] [Cited by in Crossref: 73] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
146 Shetty AK, Maldonado YA. Current Trends in Streptococcus pneumoniae Infections and Their Treatment. Curr Pediatr Rep 2013;1:158-69. [DOI: 10.1007/s40124-013-0021-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine 2011;29:9123-6. [DOI: 10.1016/j.vaccine.2011.10.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
148 Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012-1020. [PMID: 19225097 DOI: 10.1128/jcm.01454-08] [Cited by in Crossref: 179] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
149 Hanage WP. Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol 2008;3:23-30. [PMID: 18230031 DOI: 10.2217/17460913.3.1.23] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
150 Moreno J, Hernández E, Sanabria O, Castañeda E. Detection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay. J Clin Microbiol 2005;43:6152-4. [PMID: 16333118 DOI: 10.1128/JCM.43.12.6152-6154.2005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
151 Thomas JC, Kong Y, Sabharwal V, Pelton SI, Pettigrew MM. Streptococcus pneumoniae serotype 6C: an intra- and interclonal complex comparison. J Bacteriol 2011;193:3409-10. [PMID: 21551297 DOI: 10.1128/JB.05079-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
152 Telles JN, Richard N, Gillet Y, Hartwig S, Pouzol S, Dollet S, Messaoudi M, Paredes E, Ploton C, Lina G, Vernet G, Floret D, Javouhey E, Paranhos-Baccalà G. Viral and bacterial pathogens identification in children hospitalised for severe pneumonia and parapneumonic empyema. Pneumonia (Nathan) 2012;1:11-9. [PMID: 31463179 DOI: 10.15172/pneu.2012.1/228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
153 Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011;30:551-5. [PMID: 21297521 DOI: 10.1097/INF.0b013e31821038d9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
154 Ampofo K, Byington C. Management of parapneumonic empyema. Pediatr Infect Dis J 2007;26:445-6. [PMID: 17468658 DOI: 10.1097/01.inf.0000261011.23728.dd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
155 Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, Dal-Ré R, García-de-Lomas J. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob Agents Chemother. 2010;54:2953-2959. [PMID: 20439616 DOI: 10.1128/aac.01548-09] [Cited by in Crossref: 67] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
156 Calbo E, Garau J. Invasive Pneumococcal Disease in Children: Changing Serotypes and Clinical Expression of Disease. Clinical Infectious Diseases 2005;41:1821-2. [DOI: 10.1086/498316] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
157 Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008;14:275-81. [PMID: 18258121 DOI: 10.3201/eid1402.070807] [Cited by in Crossref: 204] [Cited by in F6Publishing: 193] [Article Influence: 14.6] [Reference Citation Analysis]
158 Mendes RE, Costello AJ, Jacobs MR, Biek D, Critchley IA, Jones RN. Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine. Diagn Microbiol Infect Dis 2014;80:19-25. [PMID: 24974272 DOI: 10.1016/j.diagmicrobio.2014.05.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
159 Burgos J, Falcó V, Pahissa A. The increasing incidence of empyema. Curr Opin Pulm Med 2013;19:350-6. [PMID: 23508113 DOI: 10.1097/MCP.0b013e3283606ab5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
160 Hagerman A, Posfay-Barbe KM, Grillet S, Ochs MM, Brookes RH, Greenberg D, Givon-Lavi N, Dagan R, Siegrist CA. Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia. Clin Microbiol Infect 2012;18:756-62. [PMID: 21851490 DOI: 10.1111/j.1469-0691.2011.03629.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
161 Hernández-bou S, García-garcía JJ, Esteva C, Gené A, Luaces C, Almagro CM. Pediatric parapneumonic pleural effusion: Epidemiology, clinical characteristics, and microbiological diagnosis: Pediatric Parapneumonic Pleural Effusion. Pediatr Pulmonol 2009;44:1192-200. [DOI: 10.1002/ppul.21114] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
162 Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007;44:1569-76. [PMID: 17516400 DOI: 10.1086/518149] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
163 Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia AT. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J 2010;29:712-6. [PMID: 20661100 DOI: 10.1097/INF.0b013e3181db03a7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
164 Haji T, Byrne A, Kovesi T. Trends in Pediatric Complicated Pneumonia in an Ontario Local Health Integration Network. Children (Basel) 2018;5:E36. [PMID: 29510484 DOI: 10.3390/children5030036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Norton NB, Stanek RJ, Mufson MA. Routine pneumococcal vaccination of children provokes new patterns of serotypes causing invasive pneumococcal disease in adults and children. Am J Med Sci 2013;345:112-20. [PMID: 22814362 DOI: 10.1097/MAJ.0b013e3182517785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
166 Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, Greenwood BM, Corrah T. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 2006;11:1128-35. [PMID: 16827713 DOI: 10.1111/j.1365-3156.2006.01652.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
167 Obaro SK, Madhi SA. Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining? Lancet Infect Dis 2006;6:150-61. [PMID: 16500596 DOI: 10.1016/S1473-3099(06)70411-X] [Cited by in Crossref: 55] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
168 Burgos J, Peñaranda M, Payeras A, Villoslada A, Curran A, Garau M, Riera M, Crespo M, Navarro J, Van den Eynde E, Planes AM, Ribera E, Pahissa A, Falcó V. Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children. J Acquir Immune Defic Syndr 2012;59:31-8. [PMID: 22156821 DOI: 10.1097/QAI.0b013e31823d0f5f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
169 McEllistrem MC, Ransford JV, Khan SA. Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone. J Clin Microbiol 2007;45:97-101. [PMID: 17093036 DOI: 10.1128/JCM.01658-06] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
170 Cunningham M, Guardiani E, Kim HJ, Brook I. Otitis media. Future Microbiology 2012;7:733-53. [DOI: 10.2217/fmb.12.38] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
171 Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO. The changing epidemiology of invasive pneumococcal disease at a tertiary children’s hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012;31:228-234. [PMID: 22330164 DOI: 10.1097/inf.0b013e31823dcc72] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
172 Lisboa T, Waterer GW, Lee YC. Pleural infection: changing bacteriology and its implications. Respirology 2011;16:598-603. [PMID: 21382129 DOI: 10.1111/j.1440-1843.2011.01964.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
173 Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine 2011;29:5731-9. [PMID: 21696869 DOI: 10.1016/j.vaccine.2011.05.095] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
174 de Roux A, Schmöele‐thoma B, Siber G, Hackell J, Kuhnke A, Ahlers N, Baker S, Razmpour A, Emini E, Fernsten P, Gruber W, Lockhart S, Burkhardt O, Welte T, Lode H. Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory. CLIN INFECT DIS 2008;46:1015-23. [DOI: 10.1086/529142] [Cited by in Crossref: 182] [Cited by in F6Publishing: 157] [Article Influence: 13.0] [Reference Citation Analysis]
175 Nyambat B, Kilgore PE, Yong DE, Anh DD, Chiu CH, Shen X, Jodar L, Ng TL, Bock HL, Hausdorff WP. Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease. BMC Infect Dis 2008;8:90. [PMID: 18620553 DOI: 10.1186/1471-2334-8-90] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
176 Ceyhan M, Ozsurekci Y, Gürler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, Alhan E, Baki A, Oner AF, Uzun H, Kurugol Z, Aycan AE, Gurbuz V, Karadag Oncel E, Celik M, Ozkaya Parlakay A. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey. Clin Vaccine Immunol 2013;20:972-6. [PMID: 23637041 DOI: 10.1128/CVI.00765-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
177 Barricarte A, Gil-Setas A, Torroba L, Castilla J, Petit A, Polo I, Arriazu M, Irisarri F, García Cenoz M. [Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine]. Med Clin (Barc). 2007;129:41-45. [PMID: 17588359 DOI: 10.1157/13106935] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
178 Mesher D, Soldan K, Howell-Jones R, Panwar K, Manyenga P, Jit M, Beddows S, Gill ON. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine 2013;32:26-32. [PMID: 24211166 DOI: 10.1016/j.vaccine.2013.10.085] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]